588 related articles for article (PubMed ID: 8676081)
1. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance.
Neurath MF; Fuss I; Kelsall BL; Presky DH; Waegell W; Strober W
J Exp Med; 1996 Jun; 183(6):2605-16. PubMed ID: 8676081
[TBL] [Abstract][Full Text] [Related]
2. Peyer's patches are required for oral tolerance to proteins.
Fujihashi K; Dohi T; Rennert PD; Yamamoto M; Koga T; Kiyono H; McGhee JR
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3310-5. PubMed ID: 11248075
[TBL] [Abstract][Full Text] [Related]
3. Treatment of experimental (Trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-beta1 plasmid: TGF-beta1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor beta2 chain downregulation.
Kitani A; Fuss IJ; Nakamura K; Schwartz OM; Usui T; Strober W
J Exp Med; 2000 Jul; 192(1):41-52. PubMed ID: 10880525
[TBL] [Abstract][Full Text] [Related]
4. The interrelated roles of TGF-beta and IL-10 in the regulation of experimental colitis.
Fuss IJ; Boirivant M; Lacy B; Strober W
J Immunol; 2002 Jan; 168(2):900-8. PubMed ID: 11777988
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid) colitis.
Boirivant M; Fuss IJ; Ferroni L; De Pascale M; Strober W
J Immunol; 2001 Mar; 166(5):3522-32. PubMed ID: 11207312
[TBL] [Abstract][Full Text] [Related]
6. Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice.
Santos LM; al-Sabbagh A; Londono A; Weiner HL
Cell Immunol; 1994 Sep; 157(2):439-47. PubMed ID: 7520838
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation.
Strober W; Kelsall B; Fuss I; Marth T; Ludviksson B; Ehrhardt R; Neurath M
Immunol Today; 1997 Feb; 18(2):61-4. PubMed ID: 9057354
[TBL] [Abstract][Full Text] [Related]
8. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
[TBL] [Abstract][Full Text] [Related]
9. Antigen-specific, CD4+CD25+ regulatory T cell clones induced in Peyer's patches.
Tsuji NM; Mizumachi K; Kurisaki J
Int Immunol; 2003 Apr; 15(4):525-34. PubMed ID: 12663682
[TBL] [Abstract][Full Text] [Related]
10. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses.
Dohi T; Fujihashi K; Rennert PD; Iwatani K; Kiyono H; McGhee JR
J Exp Med; 1999 Apr; 189(8):1169-80. PubMed ID: 10209035
[TBL] [Abstract][Full Text] [Related]
11. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells.
Di Giacinto C; Marinaro M; Sanchez M; Strober W; Boirivant M
J Immunol; 2005 Mar; 174(6):3237-46. PubMed ID: 15749854
[TBL] [Abstract][Full Text] [Related]
12. The role of small intestinal antigen-presenting cells in the induction of T-cell reactivity to soluble protein antigens: association between aberrant presentation in the lamina propria and oral tolerance.
Harper HM; Cochrane L; Williams NA
Immunology; 1996 Nov; 89(3):449-56. PubMed ID: 8958061
[TBL] [Abstract][Full Text] [Related]
13. An intra-Peyer's patch gene transfer model for studying mucosal tolerance: distinct roles of B7 and IL-12 in mucosal T cell tolerance.
Chen Y; Song K; Eck SL
J Immunol; 2000 Sep; 165(6):3145-53. PubMed ID: 10975828
[TBL] [Abstract][Full Text] [Related]
14. High dose oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis.
Marth T; Strober W; Kelsall BL
J Immunol; 1996 Sep; 157(6):2348-57. PubMed ID: 8805632
[TBL] [Abstract][Full Text] [Related]
15. CC chemokine ligand 2 and its receptor regulate mucosal production of IL-12 and TGF-beta in high dose oral tolerance.
DePaolo RW; Rollins BJ; Kuziel W; Karpus WJ
J Immunol; 2003 Oct; 171(7):3560-7. PubMed ID: 14500652
[TBL] [Abstract][Full Text] [Related]
16. Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression.
Chen Y; Inobe J; Weiner HL
J Immunol; 1995 Jul; 155(2):910-6. PubMed ID: 7541826
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to interleukin 12 abrogate established experimental colitis in mice.
Neurath MF; Fuss I; Kelsall BL; Stüber E; Strober W
J Exp Med; 1995 Nov; 182(5):1281-90. PubMed ID: 7595199
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10-secreting Peyer's patch cells are responsible for active suppression in low-dose oral tolerance.
Tsuji NM; Mizumachi K; Kurisaki J
Immunology; 2001 Aug; 103(4):458-64. PubMed ID: 11529936
[TBL] [Abstract][Full Text] [Related]
19. Prevention of experimental colitis by parenteral administration of a pathogen-derived immunomodulatory molecule.
Braat H; McGuirk P; Ten Kate FJ; Huibregtse I; Dunne PJ; Hommes DW; Van Deventer SJ; Mills KH
Gut; 2007 Mar; 56(3):351-7. PubMed ID: 16952913
[TBL] [Abstract][Full Text] [Related]
20. Oral tolerance to haptens: intestinal epithelial cells from 2,4-dinitrochlorobenzene-fed mice inhibit hapten-specific T cell activation in vitro.
Galliaerde V; Desvignes C; Peyron E; Kaiserlian D
Eur J Immunol; 1995 May; 25(5):1385-90. PubMed ID: 7774642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
